EDITAS MEDICINE, INC. Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants
EDITAS MEDICINE, INC. (EDIT) reported Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants of $37.04 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-08.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants · last filed 2018-03-08
- EDITAS MEDICINE, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2015-12-31 was $0.00.
- EDITAS MEDICINE, INC. stock and warrants issued during period, value, preferred stock and warrants for the quarter ending 2015-09-30 was $0.00.
- EDITAS MEDICINE, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2015 was $37.04M, a 9856.45% increase from fiscal 2014.
- EDITAS MEDICINE, INC. stock and warrants issued during period, value, preferred stock and warrants for fiscal 2014 was $372.00K.
| Period end | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 3 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 6 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 9 month | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $37.04M 10-K · filed 2018-03-08 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $37.04M 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $37.04M 10-Q · filed 2016-08-10 | |||
| 2014-12-31 | $372.00K 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |